Users of this system, can login to view this document.

Login

Enter the following information to request a copy of the document from the responsible person.

Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study

This email address is used for sending the document.